Choosing between a DAPA agreement and an FSS schedule is one of the most important decisions medical and pharmaceutical manufacturers make when entering federal healthcare. Both are powerful contract platforms, but they serve different agencies, products, and distribution models. If you treat them as interchangeable, you’ll waste time and miss opportunities. If you understand how they work and when to use each, you can build a faster, more coherent federal strategy.

Lovell Government Services, a Service‑Disabled Veteran‑Owned Small Business (SDVOSB) and federal medical distributor, helps manufacturers navigate these choices every day. This guide, “DAPA vs. FSS: Which Is Right for You?”, explains what each contract type does, how they differ, and how Lovell can help you decide—and execute—the right path for your portfolio.

The Basics: What Are DAPA and FSS?

Before you can compare, you need clear definitions.

What is a DAPA agreement?

A Distribution and Pricing Agreement (DAPA) is a contract used primarily by the Defense Logistics Agency (DLA) for medical and surgical products. In simple terms:

  • DAPA sets authorized prices for your products that DLA’s prime vendors can use when selling to military treatment facilities and some VA locations connected to DoD distribution.
  • It is closely tied to med‑surg and equipment distribution through DLA’s Medical supply chain.
  • It does not guarantee volume by itself; it makes your products price‑available to the network that supports DoD healthcare (and certain VA use cases).

For manufacturers, a DAPA agreement is your entry point into DoD’s structured medical distribution system.

What is an FSS schedule?

A Federal Supply Schedule (FSS)—most often referring to VA Federal Supply Schedules for healthcare—is a long‑term, multiple‑award contract for commercial products and services. In practice:

  • An FSS schedule sets pre‑negotiated prices and terms for your products so VA and other federal agencies can purchase them more easily.
  • VA FSS schedules cover medical equipment, supplies, pharmaceuticals, and some services.
  • FSS contracts are often the primary route the VA uses to access commercial healthcare products across its system.

For manufacturers, an FSS schedule is your “front door” into VA purchasing workflows.

High-Level Comparison: DAPA vs. FSS

Here’s a simple way to think about the two:

  • FSS schedule
    • Focus: VA (with some use by other agencies)
    • Role: Master price and terms for direct federal purchasing
    • Best for: Broad VA access to med‑surg, devices, and certain therapies
  • DAPA agreement
    • Focus: DoD (with some VA overlap through DLA)
    • Role: Price framework feeding prime‑vendor distribution
    • Best for: Med‑surg products and devices flowing through military distribution networks

Neither is “better” in the abstract. The right choice—or combination—depends on your products, target agencies, and distribution strategy.

When an FSS Schedule Makes Sense

Ask yourself these questions:

1. Is the VA your primary target?

If:

  • Your products address chronic conditions common in Veterans.
  • You already have interest from VA clinicians or facilities.
  • You see VA as a major long‑term market for your portfolio.

Then an FSS schedule is often the first contract to consider. VA contracting and logistics teams are accustomed to using FSS as a preferred or required source for many medical categories.

2. Are your products a good fit for existing VA FSS categories?

VA FSS schedules are organized by product type (medical equipment, supplies, dental, pharma, etc.). If your products line up neatly with those categories:

  • It’s easier to make the case that you belong on a schedule.
  • VA reviewers can see where your SKUs would sit in their internal catalogs.
  • Prime vendors and other VA programs can reference your FSS price file directly.

Lovell can help you map your SKUs to the appropriate FSS categories and determine if they can be added under Lovell’s existing schedule contracts.

3. Do you want predictable, national VA pricing?

FSS contracts:

  • Establish national pricing that VA facilities can rely on.
  • Provide a consistent basis for BPAs, local agreements, and formulary decisions.
  • Make it simpler to forecast margins and revenue across VA sites.

If you’re aiming for wide VA adoption and prefer a stable pricing framework, FSS is usually the right foundation.

When a DAPA Agreement Makes Sense

Now look at your DoD and DLA potential.

1. Are military treatment facilities a key focus?

If your products:

  • Are used in operating rooms, clinics, or wards at Army, Navy, Air Force, or other military hospitals.
  • Support deployment or readiness missions.
  • Align with DoD clinical priorities (trauma, orthopedics, rehab, infection control, etc.).

Then DAPA becomes critical. DLA uses DAPA pricing to support its prime‑vendor agreements, which feed inventory to those facilities.

2. Will you rely on prime‑vendor distribution?

DAPA is tightly connected to:

  • Prime vendors that stock and deliver med‑surg items to DoD facilities.
  • Catalog systems military buyers use to order routine supplies.

If your distribution strategy is built around those networks, DAPA ensures:

  • Your products are available at defined prices to those prime vendors.
  • DoD customers can find and order your items through familiar channels.
  • You can participate in broader med‑surg programs without negotiating separate prices every time.

Lovell helps manufacturers integrate DAPA pricing with a government‑ready distribution model so product actually flows once prices are set.

3. Are you targeting certain VA sites that piggyback on DLA?

Some VA facilities use DLA’s medical supply chain for specific categories. In those cases:

  • DAPA pricing can influence what they see and buy.
  • Being on DAPA helps keep you in the mix when these facilities source through DLA.

If your clinical fit spans both VA and DoD, a dual strategy using FSS for VA and DAPA for DoD can be powerful.

Scenarios: DAPA vs. FSS for Different Manufacturers

To make the choice more concrete, consider these example scenarios.

Scenario 1: Wound Care Manufacturer Focused on VA

Your portfolio:

  • Advanced dressings and negative pressure wound therapy accessories.
  • Strong evidence in chronic wound healing and diabetic foot ulcers.

Best path:

  • Start with FSS: Secure a VA FSS schedule presence in the relevant medical/surgical category.
  • Use Lovell to place products under existing FSS contracts where appropriate and handle distribution.
  • Once VA adoption grows, explore whether DAPA is useful for DoD trauma and rehab applications.

Scenario 2: Med‑Surg Supplier Focused on DoD Operating Rooms

Your portfolio:

  • Surgical instruments, drapes, gowns, and procedural kits.
  • Strong history with commercial ORs but minimal federal presence.

Best path:

  • Start with DAPA: Align SKUs with DLA med‑surg categories and secure DAPA pricing.
  • Work with Lovell to flow product through prime‑vendor distribution to military ORs.
  • As you see cross‑over interest from VA, use Lovell to pursue FSS placement for VA adoption.

Scenario 3: Device Company Serving Both VA Cardiology and DoD Trauma

Your portfolio:

  • Monitoring or imaging technology relevant in cardiology and emergency medicine.
  • Strong interest from both VA and DoD clinicians.

Best path:

  • Pursue both FSS and DAPA, but in a planned sequence:
    • Use FSS to establish national VA pricing and visibility.
    • Use DAPA to feed DoD prime‑vendor distribution.
  • Coordinate pricing and messaging through Lovell so your VA and DoD efforts reinforce, not conflict with, each other.

Key Differences to Consider: DAPA vs. FSS

As you decide, keep these structural differences in mind:

  • Agency focus
    • FSS: Primarily VA (with some use by other agencies).
    • DAPA: Primarily DoD (with some VA use via DLA).
  • How buyers interact
    • FSS: Contracting officers and facilities order directly against established schedules.
    • DAPA: Prime vendors and DLA use DAPA prices to support catalog and distribution.
  • Role in your strategy
    • FSS: Often your central VA pricing vehicle and gateway to facility‑level agreements.
    • DAPA: Your pricing gateway into DoD’s med‑surg logistics network.
  • Operational implications
    • FSS: You need a vendor‑of‑record and distribution solution that understands VA’s expectations.
    • DAPA: You need a distribution partner integrated with DLA’s prime‑vendor environment.

Lovell’s experience in both domains helps ensure you choose—and implement—the right mix.

How Lovell Helps You Decide and Execute

Lovell Government Services doesn’t just hold contracts; it acts as a strategic guide and operational partner for manufacturers weighing DAPA vs. FSS.

Here’s how Lovell supports you:

1. Portfolio and Market Assessment

Lovell works with you to:

  • Analyze your products’ fit across VA and DoD clinical programs.
  • Prioritize where federal demand is most likely to emerge first.
  • Identify whether FSS, DAPA, or a combination makes the most sense as an initial focus.

This prevents a scattershot approach and aligns contract efforts with real demand.

2. Contract Pathway Design

Once priorities are clear, Lovell helps:

  • Map SKUs to specific FSS categories or DLA DAPA segments.
  • Determine where products can be added under Lovell’s existing contracts vs. where new awards are needed.
  • Coordinate pricing strategy so that FSS and DAPA terms support, rather than undermine, each other.

You get a structured plan instead of ad hoc moves.

3. Offer Preparation and Submission Support

For both FSS and DAPA:

  • Lovell assists with data collection, formatting, and submission logistics.
  • Helps you avoid common errors that cause delays or rejections.
  • Communicates with agencies and program offices when clarifications are needed.

Expert navigation reduces cycles and increases the likelihood of timely awards.

4. Integrated Distribution and Vendor‑of‑Record Services

Once contracts are in place:

  • Lovell acts as vendor‑of‑record for VA and DoD facilities, making ordering easier.
  • Manages healthcare‑grade warehousing, inventory, and shipping.
  • Ensures orders reference correct contract numbers, items, and prices.

This is where the contract becomes a real channel, not just a number in a system.

5. Ongoing Optimization

As adoption grows:

  • Lovell monitors sales and usage patterns across VA and DoD.
  • Suggests where additional SKUs, contract modifications, or new agreements could unlock more value.
  • Helps coordinate cross‑agency strategies so a success in one system informs moves in the other.

Your DAPA and FSS presence evolves along with your federal business, not stagnates.

Common Mistakes in Choosing DAPA vs. FSS

Manufacturers often run into these pitfalls:

  • Chasing both at once without a plan
    Trying to secure FSS and DAPA simultaneously without knowing which agency or product line is primary can overload internal teams and delay everything.
  • Ignoring VA or DoD stakeholders while focusing only on contracts
    Contracts alone don’t create demand; you still need clinician and program engagement. Those conversations should be tied to contract strategy, not separate from it.
  • Underestimating operational needs
    Securing a DAPA agreement or FSS schedule without a government‑ready distribution partner leads to frustrated facilities and underused contracts.
  • Viewing DAPA vs. FSS as an either/or when both would help
    In many cases, the best answer is “first FSS, then DAPA,” or vice versa—not permanently choosing one and ignoring the other.

Lovell’s role is to help you avoid these traps and focus on moves that actually advance your federal goals.

Choose and Use DAPA and FSS Strategically with Lovell

“DAPA vs. FSS: Which Is Right for You?” is not a theoretical question—it’s a practical decision that shapes how quickly and effectively your products reach VA and DoD clinicians. The right choice depends on your portfolio, target agencies, and willingness to build or partner for government‑ready distribution and contracting.

Lovell Government Services, an SDVOSB specializing in federal healthcare, is ready to help you:

  • Evaluate whether a DAPA agreement, an FSS schedule, or both should be part of your strategy.
  • Map your products to appropriate contract categories and design a phased federal plan.
  • Back up those contracts with proven, compliant distribution to VA and DoD facilities.

If you’re ready to stop guessing and start making informed decisions about DAPA vs. FSS, visit lovellgov.com and connect with the Lovell team. Together, you can build a federal channel that uses the right vehicles for the right products—and delivers real value to the Veterans, service members, and patients your solutions are built to serve.

Lovell Government Services and SetPoint Medical partner to deliver FDA-approved neuroimmune therapy for rheumatoid arthritis to federal agencies

PENSACOLA, FL, UNITED STATES, April 22, 2026 /EINPresswire.com/ — Lovell® Government Services and SetPoint Medical, a commercial-stage medical technology company focused on improving care for patients living with chronic autoimmune diseases, today announced a strategic partnership to provide access to the Setpoint System® for treatment of rheumatoid arthritis (RA) across federal healthcare systems, including the Veterans Health Administration (VHA), Military Health System (MHS), and Indian Health Service (IHS).

Under the agreement, Lovell will serve as SetPoint Medical’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, enabling streamlined access to the company’s innovative therapeutic platform through established federal contracting channels.

SetPoint Medical’s FDA-approved SetPoint System represents a breakthrough in the treatment of RA as the first neuroimmune modulation therapy of its kind. Designed for patients who do not respond to or cannot tolerate biologic or targeted drug therapies, the SetPoint System is an implantable device that stimulates the left vagus nerve for one minute daily to activate innate anti-inflammatory pathways that regulate immune system activity, reduce inflammation, and restore immunologic balance.

Indicated for adults with moderately-to-severely active RA who are not adequately managed by existing advanced therapies, including biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs), the SetPoint System is currently the only FDA-approved neuroimmune modulation device for treatment of RA.

“Partnering with Lovell Government Services marks an important step forward in our mission to expand access to SetPoint Therapy for those living with rheumatoid arthritis,” said Murthy Simhambhatla, CEO of SetPoint Medical. “Lovell’s deep expertise in serving federal healthcare systems, combined with our commitment to advancing neuroimmune modulation, creates a promising partnership to better support RA patients. We are excited to work together to bring our technology to our veterans and deliver meaningful clinical impact.”

As SetPoint Medical’s SDVOSB partner, Lovell will facilitate availability of the SetPoint System through its Federal Supply Schedule (FSS) contract, with activation expected within 30–60 days. The product will also be accessible through additional federal procurement platforms, including GSA Advantage, DLA ECAT, and DoD DAPA. This approach simplifies the acquisition process while supporting federal agencies in meeting SDVOSB procurement goals.

“SetPoint Medical’s innovative approach to treating rheumatoid arthritis represents a meaningful advancement for patients who have limited options,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “We are proud to partner with SetPoint to expand access to this groundbreaking therapy across VA and DoD systems and support improved outcomes for veterans and service members.”

About SetPoint Medical
SetPoint Medical is a commercial-stage medical technology company dedicated to improving care for people living with chronic autoimmune diseases. The company’s FDA-approved SetPoint System is the first neuroimmune modulation therapy available for people living with rheumatoid arthritis (RA), offering a novel, device-based alternative for those who do not respond to or cannot tolerate biologic or targeted drug therapies. SetPoint’s proprietary integrated neurostimulation platform is designed to activate innate anti-inflammatory pathways in the vagus nerve to reduce inflammation and restore immunologic setpoint. With a vision to redefine the care of autoimmune conditions, SetPoint is also planning to evaluate its platform technology for other conditions including multiple sclerosis and Crohn’s disease. Learn more at setpointmedical.com.

About Lovell Government Services
Lovell Government Services has been a trusted SDVOSB vendor since 2013, with a proven track record of successfully introducing suppliers to the government market. A four-time Inc. 5000 honoree, Lovell is a recognized leader in the federal space. They partner with medical and pharmaceutical companies to better serve Veteran and military patient populations and win government contracts. Learn more at www.lovellgov.com

Jeff McKay
Lovell Government Services
+1 949-922-8523
jeff.m@lovellgov.com
Visit us on social media:
LinkedIn

A GSA Schedule contract is one of the most valuable assets a medical or pharmaceutical manufacturer can have for federal growth, yet many companies underestimate how powerful it is until they see it in action. A GSA Schedule (now called the Multiple Award Schedule, or MAS) is a long‑term governmentwide contract that lets agencies buy commercial products and services at pre‑negotiated prices and terms. For manufacturers partnering with Lovell Government Services, a GSA Schedule contract becomes a scalable, trusted channel into VA, DoD, and other federal healthcare buyers.

What Is a GSA Schedule Contract?

The GSA Multiple Award Schedule is a governmentwide contracting program that gives federal, state, local, and tribal agencies access to millions of commercial products and services at “fair and reasonable” prices. GSA negotiates terms once at the contract level, then buyers issue orders directly against those contracts instead of running full open‑market procurements each time.

In practice, a GSA Schedule contract is a long‑term IDIQ (indefinite delivery, indefinite quantity) agreement—typically five years with option periods—that defines:

  • What you can sell (your awarded SINs and catalog)
  • Who you can sell to (federal and other eligible entities)
  • At what ceiling prices and terms you may sell

Lovell holds a MAS contract (47QSWA23D004Y) specifically positioned to serve federal healthcare agencies, and uses this platform to connect manufacturer partners to government buyers.

Key GSA Schedule Benefits for Manufacturers

1. Easier, Faster Federal Sales

One of the biggest GSA Schedule benefits is speed. The program was built to make buying easier and faster for agencies by using pre‑negotiated prices and terms. When an agency buys through a Schedule:

  • They can skip lengthy open‑market competitions.
  • The purchase cycle can be reduced dramatically, sometimes to days instead of months.
  • Contracting officers know pricing is already vetted as fair and reasonable.

For manufacturers listed on Lovell’s MAS contract, this means your products are available through a “ready to buy” vehicle that procurement teams are encouraged to use and already trust.

2. Preferred Path for Many Buyers

Many agencies treat GSA Schedules as a preferred or default path for certain buys because they align with procurement rules and reduce protest risk. Some agency supplements even require buyers to check GSA first for certain categories (for example, IT and software), and similar preferences exist informally across other product areas.​

When your products are on a GSA Schedule contract, you are “on the shelf” in the very store where federal buyers are told to shop first.

3. Access to a Huge Federal Market

The MAS program is one of the broadest contracting vehicles in the federal space, with more than 17,000 contractors and over 25 million line items offered. Federal agencies spend tens of billions annually through GSA Schedules.

For healthcare manufacturers, this translates to:

  • Access to hundreds of authorized buying activities across civilian and defense agencies.
  • The ability to reach VA, DoD, and other health‑related offices via a single contract platform.

Lovell’s MAS contract sits alongside its VA FSS, DAPA, and ECAT positions, giving partners multiple high‑value channels into federal healthcare.

4. Reduced Competition on Each Order

Open‑market procurements can attract dozens of bidders and drag on for months. By contrast, GSA orders are competed only among Schedule holders, and in many cases buyers can solicit quotes from a limited number of vendors or even place orders directly when thresholds and rules allow.

Benefits for manufacturers include:

  • Competing in a smaller, pre‑qualified field rather than the entire marketplace.
  • Fewer “race to the bottom” pricing pressures compared with some open‑market bids, because non‑Schedule vendors are excluded.​
  • More opportunities to stand out based on value, past performance, and technical fit—not just price.

5. Implied Government Endorsement and Credibility

To award a GSA Schedule contract, GSA reviews your pricing, past performance, financial stability, and compliance posture. Once awarded, that vetting creates what many refer to as an “implied endorsement”: agencies know GSA has already examined your offerings and negotiated acceptable terms.

This credibility helps:

  • Reduce hesitation from new buyers unfamiliar with your brand.
  • Support internal justifications when contracting officers select your products.
  • Signal that your company is serious about the federal market and able to meet its standards.

Lovell’s own MAS and VA Schedule portfolio underscores its reputation as a trusted, long‑standing federal healthcare contractor.

6. Long‑Term Contract and Relationship Stability

A GSA Schedule contract is typically awarded for up to 20 years in 5‑year increments (base period plus options), subject to performance and compliance. This long horizon allows manufacturers to:

  • Invest in federal sales with confidence that the contract vehicle will be around long enough to recoup that investment.
  • Build multi‑year relationships with key agencies and facilities.
  • Pursue Blanket Purchase Agreements (BPAs) and task orders that layer on top of the Schedule for recurring business.

Combined with Lovell’s other long‑term contracts, MAS becomes part of a stable contract foundation for federal growth.

7. Flexible Pricing and Growth Options

GSA Schedules are not static; they allow for contract modifications, catalog expansion, and price adjustments under defined rules. Vendors can:

  • Add new products or services as portfolios evolve.
  • Request Economic Price Adjustments (EPAs) based on cost indices or commercial list price changes.​
  • Offer spot discounts to particular agencies or orders without resetting the entire contract price list.

This flexibility makes a GSA Schedule contract a living platform that can grow with your business rather than a one‑time transaction.

Why Use Lovell’s GSA Schedule Instead of Getting Your Own?

Many manufacturers assume they must pursue their own MAS award before selling significantly to the federal government. While that is one path, partnering with an established Schedule holder like Lovell offers important advantages—especially for medical and pharmaceutical companies.

Faster Time‑to‑Market

Getting a MAS contract can take many months from initial planning through award. By contrast, adding products under Lovell’s existing Schedule can be much faster because:

  • The base contract and SINs are already awarded.
  • Lovell’s contracting team understands the modification process and documentation GSA expects.​
  • Lovell’s status as a known performer can help keep reviews focused on the new products rather than the basic vendor profile.

For companies wanting to capture near‑term opportunities, this speed can be decisive.

Reduced Administrative and Compliance Burden

Preparing and maintaining a MAS contract requires dedicated resources to handle:

  • Proposal development, pricing disclosures, and negotiation.
  • Ongoing modifications, sales reporting, and Industrial Funding Fee (IFF) payments.
  • Audits and compliance with complex Schedule terms.

Lovell absorbs this workload for the portion of your portfolio it carries on its MAS contract, managing contract administration as part of its core service model. This lets your team stay focused on product development, clinical support, and commercial strategy.

SDVOSB Leverage on a GSA Platform

Lovell is a certified Service‑Disabled Veteran‑Owned Small Business (SDVOSB), and SDVOSB participation is a priority in many agencies’ small business goals. When agencies buy through Lovell’s GSA Schedule, they:

  • Receive the efficiency and compliance benefits of MAS.
  • Also get credit toward SDVOSB goals, which can make Lovell‑carried products more attractive than equivalent items from non‑SDVOSB vendors.

For manufacturers, this combination—GSA Schedule contract + SDVOSB partner—creates a compelling differentiator in competitive federal markets.

How GSA Schedules Fit with Other Healthcare Contract Vehicles

A GSA Schedule contract is powerful, but in healthcare it works best alongside other vehicles such as VA FSS, DAPA, and ECAT. Lovell holds positions across all of these, using each one where it is strongest:

  • VA FSS for VA‑centric pharmaceuticals and medical supplies.
  • DAPA & ECAT for DLA and DoD medical/surgical distribution.
  • GSA MAS for broader federal, state, and local buyers and cross‑agency opportunities.

This portfolio approach ensures that your products are accessible through the vehicles your target customers actually prefer and are authorized to use.

What Manufacturers Should Consider Before Pursuing GSA

Before you decide how to use a GSA Schedule contract (your own, Lovell’s, or both), consider:

  • Fit: Are your products commercially proven, with a track record you can document for GSA?
  • Demand: Are your target agencies likely to buy via GSA in your category?
  • Resourcing: Do you have internal capacity for proposal, negotiation, and ongoing maintenance, or does it make more sense to rely on a specialist partner?

For many medical and pharmaceutical manufacturers, the optimal path is to partner with Lovell to activate a near‑term presence on MAS and other vehicles, then decide over time whether a stand‑alone Schedule award also makes sense.

Unlock GSA Schedule Benefits with Lovell

A GSA Schedule contract is more than a check‑the‑box credential—it is a strategic platform that can accelerate federal sales, reduce competition on each order, and build long‑term relationships with government buyers. When you combine those GSA Schedule benefits with Lovell’s SDVOSB status, federal healthcare focus, and full portfolio of contract vehicles, you gain a powerful engine for growth in the VA, DoD, and beyond.

If you want to capture the value of a GSA Schedule contract without the delay and risk of going it alone, Lovell Government Services is ready to help. Lovell can evaluate where MAS fits into your federal strategy, align your products with the right contract pathways, and manage the day‑to‑day contract work so you can focus on innovation and patient impact.

To learn how Lovell can help you leverage GSA Schedule contracts to grow federal healthcare sales, visit lovellgov.com and connect with the Lovell team. Together, you can turn a complex contracting vehicle into a clear competitive advantage.